Skip to main content

Table 5 Unadjusted comparison of FT3, FT4 and TSH in clinical outcomes

From: Low free triiodothyronineis predicts worsen neurological outcome of patients with acute ischemic stroke: a retrospective study with bioinformatics analysis

 

Worsen outcomes (3 months)

Present

Absent

P

FT3, pmol/L

4.17 ± 0.35

4.97 ± 0.32

0.002

FT4, pmol/L

16.02 ± 1.84

16.71 ± 1.53

0.446

TSH, uIU/ml

2.15 ± 0.42

2.50 ± 0.84

0.548

  1. FT3 free triiodothyronine; FT4 free thyroxine; TSH thyroid stimulating hormone
Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us